factual
Brand-Name Drug Spending Rose 62% Post-Rebate
Medicare spending on brand-name drugs rose 62% between 2011 and 2015 even after accounting for rebates, with the sharpest price increases on commonly-used medications for diabetes, high cholesterol, and asthma rather than only on rare-condition drugs.
factualpending
Speaker
Robin FeldmanEvidence Quote
“Medicare spending for brand-name drugs, even after accounting for rebates, still rose 62% between 2011 and 2015.”
Created: 6/13/2026, 12:12:41 AM
Your notes
Loading notes...